Maverick Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $752K | Sell |
|
|||||
|
2021
Q2 | $49.6M | Sell |
|
|||||
|
2021
Q1 | $112M | Sell |
|
|||||
|
2020
Q4 | $128M | Buy |
|
|||||
|
2020
Q3 | $141M | Sell |
|
|||||
|
2020
Q2 | $165M | Sell |
|
|||||
|
2020
Q1 | $146M | Sell |
|
|||||
|
2019
Q4 | $260M | Sell |
|
|||||
|
2019
Q3 | $259M | Sell |
|
|||||
|
2019
Q2 | $307M | Buy |
|
|||||
|
2019
Q1 | $300M | Buy |
|
|||||
|
2018
Q4 | $204M | Buy |
|
|||||
|
2018
Q3 | $132M | Buy |
|
|||||
|
2018
Q2 | $67.1M | Buy |
|